Evaluating Iron Protein Succinylate Oral Solution in Treating Chronic Heart Failure and Iron Deficiency
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effect of standard heart failure therapy plus oral solution
with protein succinylate iron compared to placebo on the primary end point of 6 minute walk
distance at 24th week in patients with chronic ejection fraction reduction heart failure and
iron deficiency.
Phase:
Phase 4
Details
Lead Sponsor:
Lee's Pharmaceutical Limited
Treatments:
Iron Iron protein succinylate Pharmaceutical Solutions